The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

WEDNESDAY, Oct. 9, 2024 (HealthDay News) -- When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and ...

Kathy Bates is one of the most recognizable actresses in film and television, and fans have noticed quite a transformation as ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Kathy Bates credited both hard work and Ozempic medication for her diabetes diagnosis for helping her lose 100 pounds over a ...

Some of the most valuable health advancements in 2024 related to weight loss and metabolic health. New findings about ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...